0001225208-13-012781.txt : 20130520 0001225208-13-012781.hdr.sgml : 20130520 20130520161733 ACCESSION NUMBER: 0001225208-13-012781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130516 FILED AS OF DATE: 20130520 DATE AS OF CHANGE: 20130520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CORNELIUS JAMES M CENTRAL INDEX KEY: 0001198959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 13858583 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 doc4.xml X0306 4 2013-05-16 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001198959 CORNELIUS JAMES M BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 Common Stock, $0.10 par value 2013-05-16 4 S 0 10000.0000 43.2400 D 751824.0000 D Common Stock, $0.10 par value 2013-05-17 4 M 0 205996.0000 22.1400 A 957820.0000 D Common Stock, $0.10 par value 2013-05-17 4 S 0 10000.0000 43.0000 D 947820.0000 D Common Stock, $0.10 par value 2013-05-17 4 S 0 205996.0000 42.9800 D 741824.0000 D Executive Option (right to buy) 22.1400 2013-05-17 4 M 0 205996.0000 0.0000 D 2018-03-03 Common Stock, $0.10 par value 205996.0000 200000.0000 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.65 to $44.45, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.71 to $43.33, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.71 to $43.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. As Mr. Cornelius had attained age 60, this stock option award vested 100% on the first anniversary of the grant date, which was March 4, 2009. /s/ Robert J. Wollin, attorney-in-fact for James M. Cornelius 2013-05-20